3:51 PM · 23 October 2025

IBM earnings: Slow growth and poor guidance

Key takeaways
IBM
Stocks
IBM.US, International Business Machines Corp
-
-
Key takeaways
  • Results above consensus, but the stock fell over 7% after-hours
  • Third consecutive earnings call received coolly
  • Revenue of $16.33 billion, 9% year-over-year growth
  • Infrastructure revenue up 17%, consulting only 3.3%
  • Operating margin met expectations of 58.7% 
  • Market disappointed by slow growth in software/consulting and cautious guidance
  • Investing firms maintain moderately positive recommendations, but concerns about growth rate are increasing
IBM released its results yesterday, which at first glance appeared solid. Revenue and earnings per share exceeded market expectations, and free cash flow increased significantly year-over-year. Despite this, the investor reaction was decidedly negative. During regular trading, the stock price slipped downward, and in after-hours trading, the declines exceeded 7%.
This marks the third consecutive quarter where the earnings conference ends in disappointment.
  • Revenue for the past quarter amounted to $16.33 billion, representing an increase of over 9% year-over-year and a clear beat of the consensus set around $16.1 billion.
  • The infrastructure segment deserves special mention, growing by as much as 17%, demonstrating the resilience of traditional business lines.
  • Consulting performed much more modestly, with growth reaching only 3.3%.
  • The company also met expectations for an operating margin of 58.7%, and adjusted earnings per share rose to $2.65, surpassing forecasts.
  • Free cash flow grew to $2.37 billion, marking a 15% improvement compared to the same period last year.

So why the weak reaction?
The market was particularly disappointed with the growth rate in software and consulting, areas that investors view as natural fields for expansion and higher margin creation in the coming years.
Additionally, attention was drawn to a subtle but significant change in the wording of the management's commentary.

This year's revenue growth was described as "at least 5%" instead of the previous "over 5%."
This phrasing was interpreted as a de facto lowering of forecasts and increased concerns that revenue growth might not accelerate as previously expected.
Most investment banks maintain their recommendations at moderately positive levels. At the same time, analysts are increasingly signaling concern over the weak growth rate in key segments.
IBM remains a company with powerful assets, a broad technology portfolio, and a recognizable brand.

However, the aging corporation is increasingly struggling with the demands of today's highly dynamic and aggressive market, where investors expect consistent acceleration, especially in software and services segments.
Without clear evidence of sustained growth acceleration in these areas, each subsequent consensus beat may not be enough to reverse the negative narrative surrounding the company.

22 October 2025, 8:27 PM

Google Quantum Echoes – A Quantum Computing Breakthrough

22 October 2025, 6:47 PM

IBM Earnings Preview: Will grandfather of IT industry deliver expectations?

22 October 2025, 5:43 PM

US OPEN: Is the 'Meme Stock' Season Kicking Off?

20 October 2025, 3:16 PM

Waymo: Race against the regulators

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world